Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...

Shares of Merck slid Tuesday in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

(Reuters) -Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until ... compared with analyst forecasts of around $7.4 billion.

At just 12 years old, Juliana recently attended a cervical cancer summit and is now leading the way to help raise awareness ...

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China at least through ... would decelerate from 4.8% last year, to 4.6% in 2025 and 4.5% in 2026.